Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a chest patch outsmart sleep apnea diagnosis?

NCT ID NCT07744854

Diagnosis Sponsor: PranaQ Pte. Ltd. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This trial evaluates a new chest patch sensor designed to monitor breathing movements and sleep position, which could improve the diagnosis of sleep apnea. The sensor aims to provide additional information beyond current fingertip sensors, potentially helping to distinguish between central and obstructive sleep apnea. Researchers will compare the patch's readings with standard sleep lab measurements in 180 adults to see if it accurately tracks respiratory rate, sleep position, and apnea severity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Chest patch sensor (C-TraQ) measuring respiratory movements and sleep position
What this could lead to
If successful, this could lead to a more accurate, wearable diagnostic tool for sleep apnea that can distinguish between central and obstructive types, potentially enabling better home-based testing.
What could go wrong
The trial is relatively small and early-stage, and the sensor's accuracy must be validated against standard sleep lab measurements. It may not perform as well in real-world conditions or across diverse patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 180 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient who is scheduled for a sleep study.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects must be 18 years of age or older. Exclusion Criteria: * Opioids use * Chronic Obstructive Lung Disease, Global Initiative for Chronic Obstructive * Lung Disease (GOLD) categorization 3 or 4 * Devastating strokes, with a modified Rankin score (mRS) ≥ 4 * Interstitial lung disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sleep apnea central are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Apnea central sleep apnea syndrome obstructive sleep apnea syndrome sleep apnea syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sleep apnea central Sleep apnea, obstructives

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Taipei Veterans General Hospital

    RECRUITING

    Taipei, Taiwan, 201, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.